Ezra Cohen to Proto-Oncogene Proteins c-kit
This is a "connection" page, showing publications Ezra Cohen has written about Proto-Oncogene Proteins c-kit.
Connection Strength
0.616
-
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol. 2016 Feb; 27(2):318-23.
Score: 0.521
-
Novel molecular targeted therapies for refractory thyroid cancer. Head Neck. 2012 May; 34(5):736-45.
Score: 0.095